EMEA-000790-PIP01-09 - paediatric investigation plan

aluminium hydroxide adsorbed, depigmented glutaraldehyde polymerised, allergic extract of Phleum pratense, Dactylis glomerata, Festuca elatior, Lolium perenne and Poa pratensis pollen (grasses-mix) and birch pollen (50/50)
PIPHuman

Key facts

Active substance
aluminium hydroxide adsorbed, depigmented glutaraldehyde polymerised, allergic extract of Phleum pratense, Dactylis glomerata, Festuca elatior, Lolium perenne and Poa pratensis pollen (grasses-mix) and birch pollen (50/50)
Therapeutic area
Pneumology-allergology
Decision number
P/246/2010
PIP number
EMEA-000790-PIP01-09
Pharmaceutical form(s)
Suspension for injection
Condition(s) / indication(s)
  • Treatment of allergic rhinitis
  • Treatment of rhino-conjuctivitis
Route(s) of administration
Subcutaneous use
Contact for public enquiries

LETI Pharma GmbH

paediatrics@leti.de
Germany
Phone: +49 2302202860
Fax: +49 23022028620

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Decision date
Compliance check done
No

Decision

Share this page